Literature DB >> 12374793

Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells.

Lin Wang1, Rui Ma, Richard A Flavell, Mary E Choi.   

Abstract

Transforming growth factor-beta1 (TGF-beta1) is a potent inducer of extracellular matrix (ECM) synthesis that leads to renal fibrosis. Intracellular signaling mechanisms involved in this process remain incompletely understood. Mitogen-activated protein kinase (MAPK) is a major stress signal-transducing pathway, and we have previously reported activation of p38 MAPK by TGF-beta1 in rat mesangial cells and its role in the stimulation of pro-alpha1(I) collagen. In this study, we further investigated the mechanism of p38 MAPK activation by TGF-beta1 and the role of MKK3, an upstream MAPK kinase of p38 MAPK, by examining the effect of targeted disruption of the Mkk3 gene. We first isolated glomerular mesangial cells from MKK3-null (Mkk3-/-) and wild-type (Mkk3+/+) control mice. Treatment with TGF-beta1 induced rapid phosphorylation of MKK3 as well as p38 MAPK within 15 min in cultured wild-type (Mkk3+/+) mouse mesangial cells. In contrast, TGF-beta1 failed to induce phosphorylation of either MKK3 or p38 MAPK in MKK3-deficient (Mkk3-/-) mouse mesangial cells, indicating that MKK3 is required for TGF-beta1-induced p38 MAPK activation. TGF-beta1 selectively activated the p38 MAPK isoforms p38alpha and p38delta in wild-type (Mkk3+/+) mesangial cells, but not in MKK3-deficient (Mkk3-/-) mesangial cells. Thus, activation of p38alpha and p38delta is dependent on the activation of upstream MKK3 by TGF-beta1. Furthermore, MKK3 deficiency resulted in a selective disruption of TGF-beta1-stimulated up-regulation of pro-alpha1(I) collagen expression but not TGF-beta1 induction of fibronectin and PAI-1. These data demonstrate that the MKK3 is a critical component of the TGF-beta1 signaling pathway, and its activation is required for subsequent p38alpha and p38delta MAPK activation and collagen stimulation by TGF-beta1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374793     DOI: 10.1074/jbc.M208573200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis.

Authors:  Martine Chabaud-Riou; Gary S Firestein
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

2.  TGF-{beta}1 protects against mesangial cell apoptosis via induction of autophagy.

Authors:  Yan Ding; Jin Kuk Kim; Sung Il Kim; Hee-Jun Na; Soo Young Jun; Seon Jin Lee; Mary E Choi
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

Review 3.  Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling.

Authors:  Shaheen Ahmed; Ali Nawshad
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

4.  BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta1-induced type I collagen expression in mesangial cells.

Authors:  Joon Hyeok Kwak; Sung Il Kim; Jin Kuk Kim; Mary E Choi
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

Review 5.  Cecal ligation and puncture-induced sepsis as a model to study autophagy in mice.

Authors:  Ilias I Siempos; Hilaire C Lam; Yan Ding; Mary E Choi; Augustine M K Choi; Stefan W Ryter
Journal:  J Vis Exp       Date:  2014-02-09       Impact factor: 1.355

6.  Myofibroblast-Specific TGFβ Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy.

Authors:  Qinghang Meng; Bidur Bhandary; Md Shenuarin Bhuiyan; Jeanne James; Hanna Osinska; Iñigo Valiente-Alandi; Kritton Shay-Winkler; James Gulick; Jeffery D Molkentin; Burns C Blaxall; Jeffrey Robbins
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

Review 7.  Molecular networks underlying myofibroblast fate and fibrosis.

Authors:  April Stempien-Otero; Deok-Ho Kim; Jennifer Davis
Journal:  J Mol Cell Cardiol       Date:  2016-05-07       Impact factor: 5.000

8.  A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo.

Authors:  Jennifer Davis; Adam R Burr; Gregory F Davis; Lutz Birnbaumer; Jeffery D Molkentin
Journal:  Dev Cell       Date:  2012-09-27       Impact factor: 12.270

9.  Protein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cells.

Authors:  Sung Il Kim; Joon Hyeok Kwak; Lin Wang; Mary E Choi
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

10.  Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside.

Authors:  Subhash Basu; Rui Ma; Patrick J Boyle; Brian Mikulla; Mathew Bradley; Bradley Smith; Manju Basu; Sipra Banerjee
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.